Identifying blood biomarkers for Duchenne muscular dystrophy
Biomarker Signatures for Duchenne Muscular Dystrophy
This study is looking for helpful blood tests that can track how Duchenne muscular dystrophy (DMD) is changing and how well new treatments are working, so that doctors can better support patients with this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of Ny,binghamton NIH-funded |
| Lab location | 1 site (Binghamton, United States) |
| Project ID | NIH-10809611 on NIH RePORTER |
What this research studies
This research focuses on Duchenne muscular dystrophy (DMD), a severe muscle disease that currently lacks effective treatments. The team aims to identify blood-based biomarkers that can serve as reliable measures to monitor disease progression and response to therapies. By developing precise and reproducible assays, they hope to create tools that can be used in clinical trials to better assess the effectiveness of potential treatments. The research builds on previous findings and seeks to translate laboratory discoveries into practical clinical applications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Duchenne muscular dystrophy.
Not a fit: Patients with other forms of muscular dystrophy or unrelated muscle disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective monitoring of Duchenne muscular dystrophy, improving treatment outcomes for patients.
How similar studies have performed: Previous research has shown promise in using biomarkers for monitoring disease progression in muscular dystrophies, indicating that this approach has potential for success.
Where this research is happening
Binghamton, United States
- State University of Ny,binghamton — Binghamton, United States (Active)
Researchers
- Principal investigator: Hathout, Yetrib — State University of Ny,binghamton
- Study coordinator: Hathout, Yetrib
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.